{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:46:28Z","timestamp":1791744388838,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"publisher","award":["59-053"],"award-info":[{"award-number":["59-053"]}],"id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032332","name":"Heart Association of Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","award":["R016737003"],"award-info":[{"award-number":["R016737003"]}],"id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03333-0","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:58:06Z","timestamp":1780156686000},"page":"1749-1759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The COOL-AF 3-year prediction models for death, ischemic stroke, and major bleeding: a report from the COOL-AF registry"],"prefix":"10.1007","volume":"59","author":[{"given":"Satchana","family":"Pumprueg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulaluk","family":"Komoltri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahthit","family":"Yindeengam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rungroj","family":"Krittayaphong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"6","key":"3333_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.118.035012","volume":"139","author":"JP Bassand","year":"2019","unstructured":"Bassand JP, Virdone S, Goldhaber SZ, Camm AJ, Fitzmaurice DA, Fox KAA, Goto S, Haas S, Hacke W, Kayani G et al (2019) Early Risks of Death, Stroke\/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation. Circulation 139(6):787\u2013798","journal-title":"Circulation"},{"issue":"6","key":"3333_CR2","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/STROKEAHA.120.029295","volume":"51","author":"R Krittayaphong","year":"2020","unstructured":"Krittayaphong R, Winijkul A, Kunjara-Na-Ayudhya R, Apiyasawat S, Siriwattana K, Kanjanarutjawiwat W, Dutsadeevettakul S, Lip GYH (2020) Adherence to anticoagulant guideline for atrial fibrillation improves outcomes in Asian population: The COOL-AF Registry. Stroke 51(6):1772\u20131780","journal-title":"Stroke"},{"key":"3333_CR3","doi-asserted-by":"crossref","unstructured":"Lamberts M, Staerk L, Olesen JB, Fosbol EL, Hansen ML, Harboe L, Lefevre C, Evans D, Gislason GH (2017) Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: contemporary findings in real-life Danish Patients. J Am Heart Assoc 6(2):e004517","DOI":"10.1161\/JAHA.116.004517"},{"key":"3333_CR4","doi-asserted-by":"crossref","unstructured":"Krittayaphong R, Chantrarat T, Rojjarekampai R, Jittham P, Sairat P, Lip GYH (2020) Poor time in therapeutic range control is associated with adverse clinical outcomes in patients with non-valvular atrial fibrillation: a report from the Nationwide COOL-AF Registry. J Clin Med 9(6):1698","DOI":"10.3390\/jcm9061698"},{"issue":"38","key":"3333_CR5","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/eurheartj\/ehw233","volume":"37","author":"JP Bassand","year":"2016","unstructured":"Bassand JP, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KA, Goldhaber SZ, Goto S, Haas S, Hacke W et al (2016) Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J 37(38):2882\u20132889","journal-title":"Eur Heart J"},{"key":"3333_CR6","doi-asserted-by":"crossref","unstructured":"Krittayaphong R, Treewaree S, Yindeengam A, Komoltri C, Lip GYH (2025) Latent class analysis for the identification of phenotypes associated with increased risk in atrial fibrillation patients: the COOL-AF Registry. Thromb Haemost 126:95\u2013106","DOI":"10.1055\/a-2559-9994"},{"key":"3333_CR7","doi-asserted-by":"publisher","unstructured":"KangDS, Yang PS, Kim D, Jang E, Yu HT, Kim TH, Sung JH, Pak HN, Lip GYH, Joung B (2025) Racial differences in bleeding risks among patients with atrial fibrillation: an ecological epidemiological study comparing Korea and UK population. Thromb Haemost 2025. https:\/\/doi.org\/10.1055\/a-2690-1674","DOI":"10.1055\/a-2690-1674"},{"issue":"9","key":"3333_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/a-2269-1123","volume":"124","author":"DS Kang","year":"2024","unstructured":"Kang DS, Yang PS, Kim D, Jang E, Yu HT, Kim TH, Sung JH, Pak HN, Lee MH, Lip GYH et al (2024) Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom Subjects. Thromb Haemost 124(9):842\u2013851","journal-title":"Thromb Haemost"},{"issue":"4","key":"3333_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","volume":"121","author":"HK Kim","year":"2021","unstructured":"Kim HK, Tantry US, Smith SC Jr., Jeong MH, Park SJ, Kim MH, Lim DS, Shin ES, Park DW, Huo Y et al (2021) The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. Thromb Haemost 121(4):422\u2013432","journal-title":"Thromb Haemost"},{"issue":"17","key":"3333_CR10","doi-asserted-by":"publisher","first-page":"e034758","DOI":"10.1161\/JAHA.123.034758","volume":"13","author":"LS Johnson","year":"2024","unstructured":"Johnson LS, Benz AP, Shoamanesh A, Eikelboom JW, Ezekowitz M, Giugliano RP, Wallentin L, Ruff CT, Lopes RD, Jolly S et al (2024) Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF. J Am Heart Association 13(17):e034758","journal-title":"J Am Heart Association"},{"issue":"3","key":"3333_CR11","doi-asserted-by":"publisher","first-page":"e14371","DOI":"10.1111\/eci.14371","volume":"55","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen Y, Olier I, Ortega-Martorell S, Huang B, Ishiguchi H, Lam HM, Hong K, Huisman MV, Lip GYH et al (2025) Residual risk prediction in anticoagulated patients with atrial fibrillation using machine learning: A report from the GLORIA-AF registry phase II\/III. Eur J Clin Invest 55(3):e14371","journal-title":"Eur J Clin Invest"},{"issue":"12","key":"3333_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1055\/a-2434-9244","volume":"124","author":"T Potpara","year":"2024","unstructured":"Potpara T, Romiti GF, Sohns C (2024) The 2024 European Society of Cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician\u2019s perspective. Thromb Haemost 124(12):1087\u20131094","journal-title":"Thromb Haemost"},{"key":"3333_CR13","doi-asserted-by":"crossref","unstructured":"Chang HC, Chan YH, Kuo L, Chao TF (2025) Patient care pathways and risk assessments in patients with atrial fibrillation: a comparison of Asian versus non-Asian cohorts. Thrombosis and haemostasis","DOI":"10.1055\/a-2595-5575"},{"key":"3333_CR14","doi-asserted-by":"crossref","unstructured":"Cheng WH, Chan YH, Kuo L, Liao JN, Liu CM, Chen SA, Lip GYH, Chao TF (2025) Stroke risks in women vs men in Asian patients with atrial fibrillation: A temporal trend analysis and a comparison of the CHA(2)DS(2)-VASc and CHA(2)DS(2)-VA stroke risk stratification scores. Heart Rhythm 22:2515\u20132523","DOI":"10.1016\/j.hrthm.2025.05.067"},{"issue":"6","key":"3333_CR15","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.21037\/jtd-24-737","volume":"16","author":"H Jiang","year":"2024","unstructured":"Jiang H, Yan W, Han P, Zhang J, Miao H, Liang G, Luo X, Shen L, Liu Y, Qi L et al (2024) The predictive value of CHA2DS2-VASc score on the prognosis of patients with atrial fibrillation based on a prospective cohort study. J Thorac Dis 16(6):3932\u20133943","journal-title":"J Thorac Dis"},{"issue":"6","key":"3333_CR16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/STROKEAHA.118.024305","volume":"50","author":"JM Rivera-Caravaca","year":"2019","unstructured":"Rivera-Caravaca JM, Marin F, Vilchez JA, Galvez J, Esteve-Pastor MA, Vicente V, Lip GYH, Roldan V (2019) Refining stroke and bleeding prediction in atrial fibrillation by adding consecutive biomarkers to clinical risk scores. Stroke 50(6):1372\u20131379","journal-title":"Stroke"},{"issue":"12","key":"3333_CR17","doi-asserted-by":"publisher","first-page":"e017157","DOI":"10.1136\/bmjopen-2017-017157","volume":"7","author":"KAA Fox","year":"2017","unstructured":"Fox KAA, Lucas JE, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W et al (2017) Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. BMJ open 7(12):e017157","journal-title":"BMJ open"},{"issue":"1","key":"3333_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12872-021-02370-2","volume":"21","author":"K Methavigul","year":"2021","unstructured":"Methavigul K, Sairat P, Krittayaphong R, Investigators C-A (2021) Efficacy of R(2)CHA(2)DS(2)-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord 21(1):540","journal-title":"BMC Cardiovasc Disord"},{"key":"3333_CR19","doi-asserted-by":"crossref","unstructured":"Krittayaphong R, Winijkul A, Sairat P (2022) Left atrial diameter in the prediction of thromboembolic event and death in atrial fibrillation. J Clin Med 11(7):1838","DOI":"10.3390\/jcm11071838"},{"issue":"8","key":"3333_CR20","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/j.hrthm.2025.02.013","volume":"22","author":"MH Kim","year":"2025","unstructured":"Kim MH, Yang PS, Kim D, Jang E, Yu HT, Kim TH, Sung JH, Pak HN, Lee MH, Lip GYH et al (2025) Racial differences and similarities in atrial fibrillation epidemiology and risk factors in UK Biobank and Korean NHIS-HEALS cohort studies. Heart rhythm: official J Heart Rhythm Soc 22(8):e277\u2013e284","journal-title":"Heart rhythm: official J Heart Rhythm Soc"},{"issue":"9","key":"3333_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1055\/a-2278-8769","volume":"124","author":"DS Kang","year":"2024","unstructured":"Kang DS, Yang PS, Kim D, Jang E, Yu HT, Kim TH, Sung JH, Pak HN, Lee MH, Lip GYH et al (2024) Racial Differences in Ischemic and Hemorrhagic Stroke: An Ecological Epidemiological Study. Thromb Haemost 124(9):883\u2013892","journal-title":"Thromb Haemost"},{"key":"3333_CR22","doi-asserted-by":"crossref","unstructured":"Schulman S, Kearon C, Standardization Committee of the International Society on T (2005) Subcommittee on Control of Anticoagulation of the S, Haemostasis: Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Journal of thrombosis and haemostasis: JTH 3(4):692\u2013694","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"3333_CR23","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350:g7594","journal-title":"BMJ"},{"issue":"1","key":"3333_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S, Groupdagger P (2019) PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies. Ann Intern Med 170(1):51\u201358","journal-title":"Ann Intern Med"},{"issue":"1","key":"3333_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, Bossuyt P, Collins GS, Macaskill P, McLernon DJ, Moons KGM et al (2019) Calibration: the Achilles heel of predictive analytics. BMC Med 17(1):230","journal-title":"BMC Med"},{"key":"3333_CR26","doi-asserted-by":"publisher","first-page":"i3140","DOI":"10.1136\/bmj.i3140","volume":"353","author":"RD Riley","year":"2016","unstructured":"Riley RD, Ensor J, Snell KI, Debray TP, Altman DG, Moons KG, Collins GS (2016) External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ 353:i3140","journal-title":"BMJ"},{"key":"3333_CR27","doi-asserted-by":"crossref","unstructured":"Brier GW (1950) Verification of forecasts expressed in terms of probability. Monthly Weather Review 78(1):1\u20133","DOI":"10.1175\/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2"},{"issue":"4","key":"3333_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/ije\/dyr013","volume":"40","author":"I Tzoulaki","year":"2011","unstructured":"Tzoulaki I, Liberopoulos G, Ioannidis JP (2011) Use of reclassification for assessment of improved prediction: an empirical evaluation. Int J Epidemiol 40(4):1094\u20131105","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3333_CR29","doi-asserted-by":"publisher","first-page":"e0191592","DOI":"10.1371\/journal.pone.0191592","volume":"13","author":"JP Bassand","year":"2018","unstructured":"Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J, Fitzmaurice DA, Fox KAA, Gao H, Goldhaber SZ, Goto S et al (2018) Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation. PLoS ONE 13(1):e0191592","journal-title":"PLoS ONE"},{"key":"3333_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13886","author":"R Krittayaphong","year":"2022","unstructured":"Krittayaphong R, Kanjanarutjawiwat W, Wisaratapong T, Lip GYH (2023) Improving risk prediction for death, stroke and bleeding in Asian patients with atrial fibrillation. Eur J Clin Invest 53:e13886. https:\/\/doi.org\/10.1111\/eci.13886","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"3333_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137(2):263\u2013272","journal-title":"Chest"},{"issue":"5","key":"3333_CR32","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093\u20131100","journal-title":"Chest"},{"issue":"11\u201312","key":"3333_CR33","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/sim.4371","volume":"31","author":"G Ambler","year":"2012","unstructured":"Ambler G, Seaman S, Omar RZ (2012) An evaluation of penalised survival methods for developing prognostic models with rare events. Stat Med 31(11\u201312):1150\u20131161","journal-title":"Stat Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03333-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03333-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03333-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:37:01Z","timestamp":1791743821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03333-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3333"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03333-0","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GYHL is a Consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos, Huawei, and Skylabs (No fees are received personally). He is co-PI of the AFFIRMO project on multimorbidity in AF (grant agreement No 899871), TARGET project on digital twins for personalised management of atrial fibrillation and stroke (grant agreement No 101136244) and ARISTOTELES project on artificial intelligence for management of chronic long term conditions (grant agreement No 101080189), which are all funded by the EU\u2019s Horizon Europe Research & Innovation programme. Other authors hereby declare no personal or professional conflicts of interest relating to any aspect of this particular study.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}